Novartis (Bangladesh) Limited operates as a subsidiary of Novartis AG, a global healthcare company based in Switzerland It is a joint venture between Novartis AG (60%) and Bangladesh Government represented by Bangladesh Chemical Industries Corporation (40%). With the purpose to reimagine medicine to improve and extend people’s life, Novartis (Bangladesh) Limited has been contributing to the health of people of Bangladesh since 1973.
Novartis use science-based innovation to address some of the society's most challenging healthcare issues. Novartis discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. As part of a highly dynamic pharmaceuticals sector, Novartis has had more influence than most in shaping the health of populations worldwide. Bringing the current and all upcoming life-saving innovative solutions for the patients in Bangladesh is our utmost priority.
